Fluorodeoxyglucose Myocardial Accumulation to Assess Response to Immunosuppressive Treatment in Cardiac Sarcoidosis

JACC Cardiovasc Imaging. 2024 Jan;17(1):59-61. doi: 10.1016/j.jcmg.2023.06.024. Epub 2023 Aug 30.

Authors

Leslie T Cooper Jr¹, Prajwal Reddy²

Affiliations

¹ Mayo Clinic, Jacksonville, Florida, USA. Electronic address: Cooper.leslie@mayo.edu.
² Mayo Clinic, Jacksonville, Florida, USA.

PMID: 37656116
DOI: 10.1016/j.jcmg.2023.06.024

No abstract available

Keywords: cardiac sarcoidosis; fluorodeoxyglucose; immunosuppressive therapy; positron emission tomography.

Publication types

Editorial
Comment

MeSH terms

Cardiomyopathies* / diagnostic imaging
Cardiomyopathies* / drug therapy
Fluorodeoxyglucose F18
Humans
Myocarditis*
Myocardium
Positron-Emission Tomography
Predictive Value of Tests
Radiopharmaceuticals
Sarcoidosis* / diagnostic imaging
Sarcoidosis* / drug therapy

Substances

Fluorodeoxyglucose F18
Radiopharmaceuticals